MTOR and head and neck squamous cell carcinoma: Considering the hyperactivation of the PI3K/AKT/mTOR pathway in Head and Neck squamous cell carcinoma (HNSCC), targeting this pathway has become a significant approach for oral cancer treatment, where are responsible for in both in therapy resistance and cell proliferation to some extent [11,12,34].